ArticleActa oncologica (Stockholm, Sweden)2025

Cardiotoxicity in patients with metastatic melanoma treated with BRAF/MEK inhibitors: a real-world analysis of incidence, risk factors, and reversibility.

Jonas K Oddershede et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.